An Interview With Gastrointestinal Stromal Tumor Expert Dr. Jason Sicklick
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jason Sicklick, MD, an expert on gastrointestinal stromal tumors (GISTs).
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jason Sicklick, MD, an expert on gastrointestinal stromal tumors (GISTs).
Which of the statements below about the prognosis of gastrointestinal stromal tumor (GIST) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about GIST prognosis.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Sara Rothschild, the new executive director of the Life Raft Group.
Which of the statements below about the guidelines for gastrointestinal stromal tumor (GIST) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about GIST guidelines.
Which of the statements below about gastrointestinal stromal tumor (GIST) treatment are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about GIST treatment.
Which of the statements below about the epidemiology of gastrointestinal stromal tumor (GIST) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about GIST epidemiology.
Which of the statements below about the symptoms of gastrointestinal stromal tumor (GIST) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about GIST comorbidities.
Which of the following statements about the diagnosis of gastrointestinal stromal tumor (GIST) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about GIST diagnosis.
Rare Disease Advisor senior correspondent Larry Luxner interviews Ultragenyx CEO Dr. Emil Kakkis on the challenges of developing rare disease drugs.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Edward Neilan, MD, chief medical officer at the National Organization for Rare Disorders (NORD). This is a new position at NORD, which serves as the umbrella organization for some 330 disease-specific patient advocacy groups. NORD also sponsors the annual Rare Diseases and Orphan Products Breakthrough Summit,…